P. V. Danenberg
About
P. V. Danenberg is a scholar working on Oncology, Molecular Biology and Cancer Research.
According to data from OpenAlex, P. V. Danenberg has authored 79 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 35 papers in Molecular Biology and 26 papers in Cancer Research. Recurrent topics in P. V. Danenberg's work include Colorectal Cancer Treatments and Studies (27 papers), Cancer Genomics and Diagnostics (13 papers) and Genetic factors in colorectal cancer (13 papers). P. V. Danenberg is often cited by papers focused on Colorectal Cancer Treatments and Studies (27 papers), Cancer Genomics and Diagnostics (13 papers) and Genetic factors in colorectal cancer (13 papers). P. V. Danenberg collaborates with scholars based in United States, Germany and Japan. P. V. Danenberg's co-authors include Kathleen D. Danenberg, Cynthia G. Leichman, Heinz-Josef Lenz, Lawrence Leichman, Susan Groshen, Ralf Metzger, Dennis Salonga, K. D. Danenberg, Joaquina Baranda and C J Allegra and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
In The Last Decade
P. V. Danenberg
77 papers receiving 5.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| P. V. Danenberg United States | 28 | 3.4k | 2.5k | 1.5k | 982 | 890 | 79 | 5.4k | ||
| Masakazu Fukushima Japan | 45 | 4.6k 1.3× | 2.9k 1.1× | 2.5k 1.6× | 648 0.7× | 1.1k 1.2× | 242 | 7.6k | ||
| Markus Borner Switzerland | 43 | 3.0k 0.9× | 1.8k 0.7× | 1.8k 1.2× | 541 0.6× | 847 1.0× | 126 | 5.6k | ||
| Vincenzo Catalano Italy | 40 | 3.1k 0.9× | 1.4k 0.6× | 1.6k 1.1× | 900 0.9× | 866 1.0× | 124 | 5.1k | ||
| M. E. Scheulen Germany | 36 | 2.6k 0.8× | 2.3k 0.9× | 1.2k 0.8× | 612 0.6× | 734 0.8× | 178 | 5.5k | ||
| Robert Justice United States | 40 | 2.5k 0.7× | 2.8k 1.1× | 1.7k 1.1× | 558 0.6× | 871 1.0× | 61 | 6.4k | ||
| Ferry A.L.M. Eskens Netherlands | 43 | 2.9k 0.8× | 2.6k 1.0× | 1.5k 1.0× | 601 0.6× | 1.2k 1.4× | 161 | 6.4k | ||
| Érick Gamelin France | 42 | 4.2k 1.2× | 1.7k 0.7× | 1.0k 0.7× | 676 0.7× | 476 0.5× | 138 | 6.3k | ||
| Teresa Troiani Italy | 42 | 3.6k 1.1× | 2.4k 1.0× | 2.0k 1.3× | 836 0.9× | 1.1k 1.3× | 183 | 5.9k | ||
| Jae Kyung Roh South Korea | 30 | 4.2k 1.2× | 1.1k 0.4× | 1.8k 1.2× | 1.3k 1.4× | 862 1.0× | 156 | 5.9k | ||
| Philip C. Mack United States | 44 | 3.8k 1.1× | 2.9k 1.1× | 3.5k 2.3× | 633 0.6× | 1.9k 2.1× | 234 | 6.8k |
Countries citing papers authored by P. V. Danenberg
Since
Specialization
Citations
This map shows the geographic impact of P. V. Danenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. V. Danenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. V. Danenberg more than expected).
Fields of papers citing papers by P. V. Danenberg
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by P. V. Danenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. V. Danenberg. The network helps show where P. V. Danenberg may publish in the future.
Co-authorship network of co-authors of P. V. Danenberg
This figure shows the co-authorship network connecting the top 25 collaborators of P. V. Danenberg. A scholar is included among the top collaborators of P. V. Danenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. V. Danenberg. P. V. Danenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sunakawa, Yu, Hironaga Satake, Yuji Miyamoto, et al.. (2022). Dynamic changes in RAS gene status in circulating tumour DNA: a phase II trial of first-line FOLFOXIRI plus bevacizumab for RAS-mutant metastatic colorectal cancer (JACCRO CC-11). ESMO Open. 7(3). 100512–100512.
2.
Raez, Luis E., et al.. (2019). PD2.01 PD-L1 and Other Potential Predictive Biomarkers Measured in Plasma by RT-PCR in cfRNA and cfDNA to Monitor Clinical Responses in Metastatic Lung Cancer Patients. Journal of Thoracic Oncology. 14(11). S1170–S1170.
3.
Danenberg, Kathleen D., et al.. (2018). MA19.06 Blood Based Biomarkers: RNA, KRAS and PD-L1 Strongly Matching with Tissue and Showing Correlation with Clinical Responses In NSCLC Patient’s. Journal of Thoracic Oncology. 13(10). S423–S424.
4.
Wilson, P. M., Dongyun Yang, Mizutomo Azuma, et al.. (2012). Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib). The Pharmacogenomics Journal. 13(5). 410–416.
5.
Grimminger, Peter, Carl Barrett, David Lebwohl, et al.. (2011). TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials. The Pharmacogenomics Journal. 12(5). 404–411.
6.
Somlo, George, P Chu, Paul Frankel, et al.. (2008). Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome. Annals of Oncology. 19(11). 1853–1859.
7.
Collisson, Eric A., Dibash Kumar Das, Andreas-Claudius Hoffmann, et al.. (2008). Use of whole genome expression analysis of pancreatic adenocarcinoma to predict prognosis after OXi4503 surgery. Journal of Clinical Oncology. 26(15_suppl). 4503–4503.
8.
Gutschow, Christian A., Daniel Vallböhmer, M. Stolte, et al.. (2007). Adenocarcinoma developing in de novo Barrett's mucosa in the remnant esophagus after esophagectomy: clinical and molecular assessment. Diseases of the Esophagus. 21(3). E6–E8.
9.
Vallböhmer, Daniel, Steven R. DeMeester, Jeffrey H. Peters, et al.. (2006). Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus. Diseases of the Esophagus. 19(4). 260–266.
10.
Ceppi, Paolo, Marco Volante, Silvia Novello, et al.. (2006). ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. Annals of Oncology. 17(12). 1818–1825.
11.
Uemura, Hiroji, et al.. (2005). Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer. Prostate Cancer and Prostatic Diseases. 8(3). 260–265.
12.
Hillenbrand, Andreas, A. Formentini, Ludger Staib, et al.. (2004). A longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving hepatic arterial infusion chemotherapy. European Journal of Surgical Oncology. 30(4). 407–413.
13.
Brabender, Jan, Heinz‐Josef Lenz, & P. V. Danenberg. (2000). Molekulare Marker als Grundlage für die Chemotherapie?. Der Chirurg. 71(12). 1433–1439.
14.
Görlick, Richard, R. Metzger, Kathleen D. Danenberg, et al.. (1998). Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma.. Journal of Clinical Oncology. 16(4). 1465–1469.
15.
Metzger, R., Cynthia G. Leichman, Kathleen D. Danenberg, et al.. (1998). ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.. Journal of Clinical Oncology. 16(1). 309–316.
16.
Leichman, Cynthia G., Heinz-Josef Lenz, Lawrence Leichman, et al.. (1997). Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin.. Journal of Clinical Oncology. 15(10). 3223–3229.
17.
Lenz, Heinz-Josef, Cynthia G. Leichman, Kathleen D. Danenberg, et al.. (1996). Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival.. Journal of Clinical Oncology. 14(1). 176–182.
18.
Lenz, Heinz‐Josef, et al.. (1995). Rapid quantitative PCR for determination of relative gene expressions in tissue specimens.. Genome Research. 4(5). 305–308.
19.
Volkenandt, Matthias, Adam P. Dicker, Debabrata Banerjee, et al.. (1992). Quantitation of Gene Copy Number and mRNA Using the Polymerase Chain Reaction. Experimental Biology and Medicine. 200(1). 1–6.
20.
Link, K. H., et al.. (1988). Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT 29 colorectal carcinoma cells. Cancer Chemotherapy and Pharmacology. 22(1). 58–62.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Masakazu Fukushima Breakdown of academic impact, for papers by Markus Borner Breakdown of academic impact, for papers by Vincenzo Catalano Breakdown of academic impact, for papers by M. E. Scheulen Breakdown of academic impact, for papers by Robert Justice Breakdown of academic impact, for papers by Ferry A.L.M. Eskens Breakdown of academic impact, for papers by Érick Gamelin Breakdown of academic impact, for papers by Teresa Troiani Breakdown of academic impact, for papers by Jae Kyung Roh Breakdown of academic impact, for papers by Philip C. Mack